Cancer Research

ThromboGenics And BioInvent Announce A Strategic Alliance With Roche For TB-403, A Novel Anti-Cancer Antibody

for all future development costs for this novel therapy, including the costs of the pending Phase Ib ...

Article - Anna Ohlden - Jun 18 2008 - 12:33am

The COVID Impact on Colorectal Cancer Screening

This increases life expectancy. The goal of all countries is to reduce the burden on the health system ...

Blog Post - Smitha Dutt - Mar 3 2021 - 6:25pm

Rosetta Genomics Reports Second Quarter 2008 Financial Results

technology, all of which are in early stages of development; Rosetta's ability to obtain regulatory ...

Article - Anna Ohlden - Aug 19 2008 - 4:32am